Product & FDA Disclaimer
*FDA regulations strictly prohibit the use of therapeutic or medical claims in conjunction with the sale of any product not approved by the FDA. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
*The information and products presented on this website are not intended as a substitute for the advice or medical care of a qualified physician. No action should be taken solely on its content. You should not use the information on this web site for diagnosing or treating a health problem or disease, or prescribing any medication or other treatment.
*Dietary supplements supplied by Health & Balance Vitamins Pty Ltd should always be consumed as part of a holistic plan that incorporates nutrition, exercise, stress management and quality sleep. We do not recommend using this product in the absence of the aforementioned lifestyle factors.
*This product is a dietary supplement.
References
Dhaliwal, J. (2022). Comparing Metformin, Inositol, and Lifestyle Modifications to Improve Symptomatology of Polycystic Ovary Syndrome (PCOS): A Research Protocol. Undergraduate Research in Natural and Clinical Science and Technology Journal, 1-8.
Vyas, L., Raiturker, A. P., Sud, S., Goyyal, P., Abhyankar, M., Revankar, S., & Walia, S. (2022). Management of polycystic ovary syndrome among Indian women using myo‐inositol and D-chiro-inositol. Bioinformation, 18(2), 103.
Khatoon, R. (2022). Impact of Myo-Inositol on Ovary and Menstrual Cycle in Polycystic Ovarian Syndrome (PCOS)–A Therapeutic Approach. Pakistan Journal of Medicine and Dentistry, 11(3), 59-65.
Sigue, R. J. L., & Decena, D. D. (2022). Efficacy of Myo-inositol in Improving Pregnancy Rate and Regulation of Menstrual Cycle for Patients With Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis. Journal of Medicine, University of Santo Tomas, 6(2), 979-998.